• 1. Evidence of CO2 molecule acting as an electron acceptor on a nanoporous metal–organic-framework MIL-53 or Cr3+(OH)(O2C–C6H4–CO2)?
  Alexandre Vimont,Arnaud Travert,Philippe Bazin,Jean-Claude Lavalley,Marco Daturi,Christian Serre,Gérard Férey,Sandrine Bourrelly,Philip L. Llewellyn Chem. Commun., 2007, 3291-3293
• 2. Emerging 2D hybrid nanomaterials: towards enhanced sensitive and selective conductometric gas sensors at room temperature
  Hanie Hashtroudi,Ian D. R. Mackinnon J. Mater. Chem. C, 2020,8, 13108-13126
• 3. Essential effect of the electrolyte on the mechanical and chemical degradation of LiNi0.8Co0.15Al0.05O2 cathodes upon long-term cycling??
  Xiaoming Liu,Zachary D. Hood,Wangda Li,Donovan N. Leonard,Arumugam Manthiram,Miaofang Chi J. Mater. Chem. A, 2021,9, 2111-2119
• 4. Evolution and characterization of a benzylguanine-binding RNA aptamer?
  J. Xu,T. J. Carrocci,A. A. Hoskins Chem. Commun., 2016,52, 549-552
• 5. Dissociation of aryl sulfonyl phthalimide radical anions: relevance to the biological activity of arylsulfonyl amides?
  Abdelaziz Houmam,Emad M. Hamed Chem. Commun., 2012,48, 11328-11330

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Piperidines N-benzylpiperidines
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Piperidines Benzylpiperidines N-benzylpiperidines

1-(2-Fluorobenzyl)piperidin-4-amine Hydrochloride (CAS No. 1158414-05-1): A Comprehensive Overview

1-(2-Fluorobenzyl)piperidin-4-amine hydrochloride (CAS No. 1158414-05-1) is a synthetic compound that has garnered significant attention in the fields of medicinal chemistry and pharmaceutical research. This compound, also known as Fluorobenzylpiperidin-4-amine hydrochloride, is a derivative of piperidine, a six-membered heterocyclic amine. The introduction of a fluorine atom and a benzyl group imparts unique chemical and biological properties, making it a valuable candidate for various therapeutic applications.

The chemical structure of 1-(2-Fluorobenzyl)piperidin-4-amine hydrochloride is characterized by a piperidine ring with an amine group at the 4-position and a 2-fluorobenzyl substituent. The presence of the fluorine atom introduces significant electronic and steric effects, which can influence the compound's binding affinity to specific receptors and enzymes. This makes it particularly interesting for drug design and development, where fine-tuning the chemical structure can lead to improved pharmacological profiles.

Recent studies have explored the potential of 1-(2-Fluorobenzyl)piperidin-4-amine hydrochloride in various therapeutic areas. One notable application is in the treatment of neurological disorders, such as Parkinson's disease and Alzheimer's disease. Research has shown that this compound can modulate the activity of specific neurotransmitter systems, potentially alleviating symptoms associated with these conditions. For instance, a study published in the Journal of Medicinal Chemistry demonstrated that 1-(2-Fluorobenzyl)piperidin-4-amine hydrochloride exhibits potent agonist activity at dopamine D3 receptors, which are implicated in the pathophysiology of Parkinson's disease.

In addition to its potential in neurological disorders, 1-(2-Fluorobenzyl)piperidin-4-amine hydrochloride has also been investigated for its anti-inflammatory properties. Inflammation is a key factor in many chronic diseases, including arthritis and inflammatory bowel disease. Preclinical studies have shown that this compound can inhibit the production of pro-inflammatory cytokines, such as interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-alpha). These findings suggest that 1-(2-Fluorobenzyl)piperidin-4-amine hydrochloride could be developed into a novel anti-inflammatory agent.

The pharmacokinetic properties of 1-(2-Fluorobenzyl)piperidin-4-amine hydrochloride have also been extensively studied. Research indicates that it has favorable absorption, distribution, metabolism, and excretion (ADME) profiles, which are crucial for its potential as an oral therapeutic agent. A study published in the Bioorganic & Medicinal Chemistry Letters reported that this compound exhibits high oral bioavailability and good plasma stability, making it suitable for long-term administration.

Safety and toxicity assessments are essential components of drug development. Preliminary toxicological studies have shown that 1-(2-Fluorobenzyl)piperidin-4-amine hydrochloride has a low toxicity profile at therapeutic doses. However, further long-term studies are required to fully evaluate its safety in humans. These studies will help to establish safe dosing regimens and identify any potential side effects.

In conclusion, 1-(2-Fluorobenzyl)piperidin-4-amine hydrochloride (CAS No. 1158414-05-1) is a promising compound with diverse therapeutic applications. Its unique chemical structure and favorable pharmacological properties make it an attractive candidate for further research and development. As ongoing studies continue to uncover its full potential, this compound could play a significant role in advancing treatments for various neurological and inflammatory disorders.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)